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Dengue virus (DENV) infection is associated to exacerbated inﬂammatory response and structural and
functional alterations in the vascular endothelium. However, the mechanisms underlying DENV-
induced endothelial cell activation and their role in the inﬂammatory response were not investigated so
far. We demonstrated that human brain microvascular endothelial cells (HBMECs) are susceptible to
DENV infection, which induces the expression of the cytoplasmic pattern recognition receptor (PRR)
RIG-I . Infection of HBMECs promoted an increase in the production of type I IFN and proinﬂammatory
cytokines, which were abolished after RIG-I silencing. DENV-infected HBMECs also presented a higher
ICAM-1 expression dependent on RIG-I activation as well. On the other hand, ablation of RIG-I did not
interfere with virus replication. Our data suggest that RIG-I activation by DENV may participate in the
disease pathogenesis through the modulation of cytokine release and expression of adhesion molecules,
probably contributing to leukocyte recruitment and ampliﬁcation of the inﬂammatory response.
& 2012 Elsevier Inc. All rights reserved.Introduction
Dengue is the most important arthropod-borne human viral
disease, with 2.5 billion people at risk, 50–100 million infections
and thousands of deaths annually (TDR/WHO, 2006, 2009). It is
caused by dengue virus (DENV), a single stranded RNA virus that
belongs to the Flaviviridae family. DENV infection may be asympto-
matic or cause a mild self-limited fever, dengue fever (DF), but may
also evolve to the severe and life-threatening diseases known as
dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)
(TDR/WHO, 2006, 2009; Halstead et al., 1970; Guzman et al., 2010).
Many studies have attempted to understand the mechanisms
involved in the progression to the severe forms of the disease but,
despite of these efforts, the pathogenesis of dengue is not entirely
understood, probably because it is a result of an intricate interaction
between host, virus and environmental factors (Clyde et al., 2006).
The main symptoms of DHF/DSS are the loss of intravascular
ﬂuid volume, with consequent raised hematocrit, hypotension
and serous effusions, which point to alterations in the vascular
endothelium as a major event in the disease progression (Basull rights reserved.
a Poian),and Chaturvedi, 2008). Endothelium is responsible for maintain-
ing blood ﬂuidity, regulation of blood ﬂow and control of vessel
wall permeability and, as part of the innate immune system,
endothelial cells respond to pathogens with structural changes
and with production of inﬂammatory cytokines (Opitz et al.,
2009). Those cytokines can dramatically alter endothelial cells
structure, and contribute to the ampliﬁcation of the inﬂammatory
response (Basu and Chaturvedi, 2008). Over-activation of endothe-
lial cells can lead to coagulopathy, increased vascular permeability,
arterial hypotension and organ dysfunction (Opitz et al., 2009), the
symptoms of severe dengue. Indeed, the ﬂuid and protein leakage
observed in severe dengue has been attributed to a massive release
of cytokines from cells activated upon DENV infection (Clyde et al.,
2006; Pang et al., 2007; Basu and Chaturvedi, 2008).
Viral proteins or nucleic acids contain structural components
considered as pathogen-associated molecular patterns (PAMPs).
These molecules are recognized by the pattern-recognition receptors
(PRRs), which are expressed in different cell types and are key
elements of the innate immune response. Engagement of PRRs
triggers signaling pathways that ultimately activate the production
of type I interferons and pro-inﬂammatory cytokines (Takeuchi and
Akira, 2009). Viral dsRNAs produced during the replication of RNA
viruses are recognized by PRRs such as the retinoic acid inducible
gene-I (RIG-I)-like receptors (RLRs) (Yu and Levine, 2011). The
interaction between RLRs and the viral RNA mediates the activation
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type I interferons (IFN-a/b), as well as the activation of NF-kB and
AP-1 transcription factors, which leads to the expression of pro-
inﬂammatory cytokines, such as IL-6 and IL-8 (Yu and Levine, 2011).
In the case of DENV infection, upregulation of RIG-I expression was
demonstrated in different cell lines (Loo et al., 2008; Conceic- ~ao et al.,
2010a; Nasirudeen et al., 2011), but this process has not been
investigated in endothelial cells so far. Since the overproduction of
immune mediators seems to provide an important contribution to
the development of DHF/DSS, it is of great interest to evaluate and to
understand the role of the PRRs, especially RIG-I, and the conse-
quence of their activation, in endothelial cells.
In the present work we investigated the responses of an
endothelial cell line, the human brain microvascular endothelial
cells (HBMEC), to DENV infection. In particular, we evaluated the
role of RIG-I receptor activation in the production of immune
mediators by infected cells. Our results showed a considerable
increase in RIG-I expression in DENV-infected HBMEC, as well as
an enhancement in the expression of pro-inﬂammatory cytokines,
interferon-b and the Intercellular Adhesion Molecule I (ICAM-1).
Furthermore, through siRNA experiments, we found that the pro-
duction of immune mediators in infected cells was triggered by RIG-I
activation, suggesting that this pathwaymay contribute to the altered
endothelial function and exacerbated immune response characteristic
of DHF/DSS.
Results
Infection of HBMEC with DENV upregulates RIG-I expression
Several studies have demonstrated that DENV is able to infect
different endothelial cell lines, inducing morphological and functionalFig. 1. HBMECs are permissive to in vitro infection by DENV. (A–C) HBMECs were infec
(A) Viral RNA was quantiﬁed by quantitative real time PCR using DENV speciﬁc primers
infected cells was performed by plaque assay. (C) Intracellular viral proteins were detect
ﬂow cytometry; mock-treated cell are represented by gray histogram, and HBMECs infec
the numbers indicate the percentage of DENVþ cells. (D) HBMECs were cultured with U
RNA was quantiﬁed as in (A). (D) HBMECs were mock-treated or infected with DENV-2 a
p.i. Data are represented as mean7standard error of at least three independent experalterations of those cells (Avirutnan et al., 1998; Talavera et al., 2004;
Dalrymple and Mackow, 2011). To authenticate our model, we ﬁrst
analyzed whether a human brain microvascular endothelial cell
(HBMEC) would also be permissive to DENV infection. HBMECs were
cultured with DENV-2 at MOI of 1 and the presence of virus genome
was evaluated by quantitative RT-PCR after different time points.
DENV RNA was detected at 16 h p.i. and RNA levels increased over
time (Fig. 1A), indicating a productive infection of these cells. We also
analyzed the release of infectious virus by plaque assay and the peak
of virus titer was detected at 48–72 h p.i. (Fig. 1B). Flow cytometry
analyses conﬁrmed the presence of virus antigens in HBMEC, with
around 19% and 5% of the cells infected at 48 and 72 h p.i.,
respectively (Fig. 1C). We further analyzed the kinetic of virus
replication in parallel with a cell viability assay in HBMECs infected
with MOIs ranging from 0.1 to 10 and we observed that, indeed,
a MOI of 1 resulted in a consistent virus replication without a
severe loss of cell viability (Fig. 1D, E). As expected, we did not
detect signiﬁcant levels of virus RNA in HBMEC cultured with
UV-inactivated virus.
HBMEC cultured with DENV, but not with UV-inactivated
virus, showed a marked increase in RIG-I mRNA expression,
which started to be detected at 30 h p.i. and reached a thirteen-
fold increase at 48 h p.i. (Fig. 2A). This was followed by an
increase in RIG-I protein expression, which was clearly detected
after 48 h p.i., as evaluated by western blotting assay (Fig. 2B).
Also, ﬂow cytometry analysis demonstrated that approximately
9% and 39% of the cells expressed RIG-I after 24 and 48 h of DENV
infection, respectively, in comparison to 1% in the mock-treated
cultures (Fig. 2C). Interestingly, in the cultures incubated with the
virus (DENV) an increase in RIG-I expression was observed in both
infected (8.31% of the total cells, meaning 41.7% of the DENV
positive cells) and noninfected cells (41.91% of total cells,ted with DENV at a M.O.I. of 1 and infection was assessed by different techniques.
and probe. (B) Determination of infectious virus particles in the culture medium of
ed in permeabilized cells stained with mouse anti-DENV antibody and analyzed by
ted at 48 h and 72 h p.i. are represented by light and dark black lines, respectively;
V-inactivated DENV, or native virus at the indicated MOI. After 24 h and 48 h, viral
t the indicated MOIs and cell viability was evaluated by MTT assay at 24 h and 48 h
iments.
Fig. 2. DENV infection upregulates the expression of RIG-I. HBMECs were mock-infected (white bars) or infected with DENV at a M.O.I. of 1 (black bars) and RIG-I
expression was assessed at different time points. (A) RIG-I mRNA was measured, after 24, 30, and 48 h p.i., by quantitative real time PCR using speciﬁc primers for RIG-I. As
a control, RNA obtained from HBMECs cultured with UV-inactivated DENV (iDENV; striped bar) for 48 h was also analyzed. (B) RIG-I protein expression was measured by
western blotting analysis of the whole-cell lysates submitted to SDS-PAGE using anti-RIG-I antibody and anti-b-actin antibody as a loading control. Bar graphic indicate the
ratio of RIG-I protein over loading control. (C) After 24 and 48 h of infection, the cells were permeabilized, stained with anti-RIG-I antibody and analyzed by ﬂow
cytometry. Mock-treated cell are represented by gray histogram, and HBMECs infected at 24 h and 48 h p.i. are represented by light and dark black lines, respectively; the
numbers indicate the percentage of RIGþ cells. (D) After 48 h p.i., the cells were stained as in (C) and also incubated with anti-DENV antibody. The cells were analyzed by
ﬂow cytometry and the ﬁgure is a representative quadrant plot of DENV vs RIG-I staining. Insert numbers express the percentage of cells in each quadrant. Data are
represented as mean7standard error of at least three independent experiments. *po0.05 and ** po0.01.
T.M. da Conceic- ~ao et al. / Virology 435 (2013) 281–292 283meaning 52.3% of the DENV positive cells) (Fig. 2D). This result
suggests that the infected cells or soluble mediators released by
them could stimulate the bystander cells to express the receptor.
DENV infection induces the expression and secretion of pro-
inﬂammatory cytokines in a RIG-I-dependent pathway
DENV infection induces the production of IFNs and pro-
inﬂammatory cytokines by different cell types, including some
endothelial cells (Avirutnan et al., 1998; Lin et al., 2002; Talavera
et al., 2004; Conceic- ~ao et al., 2010a, b; Gandini et al., 2011).
Therefore, we investigated whether HBMECs infection would also
result in cellular activation and cytokine secretion by analyzing
the production of IFN-b, IL-6, IL-8, RANTES, IL-10 and TNF-a.
Analyses by qRT-PCR demonstrated a marked increase in the
mRNA expression of most of the investigated cytokines, except for
IL-10 and TNF-a, starting at 24–30 h p.i., with a peak at 48 h p.i.
(Fig. 3A). At this later time point, IL-6 and IL-8 mRNA levels
showed 5- and 10-fold increase, respectively, in comparison to
mock-treated cells. RANTES and IFN-b genes showed a remark-
able upregulation, reaching 253- and 2800-fold average increase
in comparison to controls (Fig. 3A). Consistently, cytokine secre-
tion was also signiﬁcantly enhanced after 48 h of DENV infection,as evaluated by ELISA (Fig. 3B). As expected, UV-inactivated virus
did not induce cytokine production by HBMECs. Importantly,
infection of the primary endothelial cell HUVEC with DENV-2
also resulted in increased expression of RIG-I, and enhanced
production of IFN-b, IL-6, IL-8 and RANTES, indicating that these
events were not restricted to the HBMEC cell line (Fig. 4A and B).
To determine whether the DENV-induced cytokine production
was due to activation of RIG-I receptor, we used RNA interference
strategy to knockdown RIG-I gene expression in HBMEC. qRT-PCR
and immunoblotting analyses conﬁrmed that transfection with
speciﬁc siRNA greatly inhibited RIG-I mRNA and protein expres-
sion (Fig. 5A and B, respectively). Importantly, RIG-I was pre-
sented at background levels even after DENV infection.
We then measured the cytokine levels in RIG-I-silenced cells.
The expression of the mRNAs for IL-6, RANTES and IFN-b, but not
for IL-8, was signiﬁcantly diminished in HBMECs infected after
RIG-I silencing (Fig. 6A). Consistently, cytokine secretion was also
strongly inhibited and cytokine concentrations in the culture
supernatants of the infected cells were similar to the ones
detected in mock-treated cells (Fig. 6B). These results indicate
that the activation of RIG-I pathway is important to the produc-
tion of IFN-b and pro-inﬂammatory mediators induced by DENV
infection of HBMEC.
Fig. 3. DENV infection induces cytokines and type I interferon production in HBMECs. HBMECs were cultured with mock-supernatants (white bars), inactivated DENV
(iDENV; striped bars), or infected with DENV at a M.O.I. of 1 (black bars). After different periods post-infection (24 h, 30 h, 48 h) the induction of cytokine production was
quantiﬁed by (A) expression of mRNA for IL-6, IL-8, RANTES, IFN-b, IL-10, and TNF-a by quantitative real time PCR using speciﬁc primers; and (B) determination of the
concentration of IL-6, IL-8 and RANTES in the culture supernatants by ELISA. Data are represented as mean7standard error of at least three independent experiments.
*po0.05.
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Activation of endothelial cells may induce structural altera-
tions to allow cell recruitment, adhesion and extravasation to the
injured tissue. Inﬂammatory mediators secreted during DENV
infection showed to mediate this activation and induce an
upregulation of the expression of adhesion molecules, such as
ICAM-1 (Anderson et al., 1997; Cardier et al., 2006).However, the direct effect of endothelial cell infection in the
expression of adhesionmolecules and themechanisms regulating this
process were not clearly addressed. We evaluated whether HBMECs
would also upregulate the expression of ICAM-1 after DENV infection
and whether RIG-I would inﬂuence in this event. Immunoblotting
analysis demonstrated that DENV infection enhanced ICAM-1 expres-
sion and that in RIG-I depleted cells, ICAM-1 levels were similar
to those of noninfected cells (Fig. 7). These results demonstrate that
Fig. 4. DENV infection induces cytokines and type I interferon production in primary HUVECs. (A) HUVECs were mock-treated or infected with DENV at a M.O.I. of 1. After
48 h post-infection the expression of mRNA for RIG-I (striped bar), IL-6, IL-8, RANTES, and IFN-b (black bars) were analyzed by quantitative real time PCR using speciﬁc
primers. (B) Supernatant of mock-treated or DENV-infected HUVECs were harvested at 48 h p.i. and the concentration of IL-6, IL-8 and RANTES was evaluated by ELISA.
Data are represented as mean7standard error of at least three independent experiments. Bars indicate the fold increase of DENV-infected over mock-treated cells.
*po0.05.
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upregulation of ICAM-1 expression induced by DENV.
RIG-I does not inﬂuence on DENV replication in HBMECs, but affects
the expression of other innate immune receptors
Since RIG-I is necessary to IFN-b production, we investigated
whether the inhibition of RIG-I expression would modulate virus
replication in HBMECs. Cells were infected after transfection with
RIG-I siRNA and the levels of viral RNA and infectious particle
release were evaluated by qRT-PCR and plaque assay, respectively
(Fig. 8A and B). The results showed that the knockdown of RIG-I
did not alter the replication of DENV in HBMEC cells, suggesting
that DENV has evolved strategies to escape from RIG-I-induced
antiviral response.
Activation and signaling mediated by innate immune recep-
tors usually inﬂuence on the activation of other related molecules
(Nasirudeen et al., 2011). We analyzed the expression of other
RNA helicases in infected HBMECs, and investigated the effect of
RIG-I silencing on this event. We observed that DENV-2 infection
induced a signiﬁcant expression of MDA-5 and Lpg2 in HBMECs
(Fig. 9). In addition, ablation of RIG-I expression resulted in a
diminished expression of both receptors, suggesting that RIG-I
activation may also modulate signaling pathways associated to
other innate immune receptors.Discussion
Dengue is a multifactorial disease whose major symptoms are
related to an exacerbated inﬂammatory response triggered by the
infection and/or activation of different cell types. In the present
work, we investigated whether a human endothelial cell line
would be permissive to DENV infection, resulting in cellular
activation, and evaluated the role of the cytoplasmic PRR RIG-I
in these processes. Human brain microvascular endothelial cell
line (HBMECs) was studied mostly as a model of endothelial cells,
but also due to possible implications in dengue pathogenesis,
given that infection or lesion of endothelial cells in the central
nervous system had been previously reported in dengue fatal
cases (Ramos et al., 1998; Limonta et al., 2007). In addition,
infection of human brain microvascular endothelial (HBMVE)
cells and of vascular ECs from a human fatal case were also
described in infection caused by other Flaviviruses, such as West
Nile Virus (WNV) and Japanese Encephalitis Virus (JEV), respec-
tively (Verma et al., 2009; German et al., 2006).We demonstrated that DENV productively infects HBMEC and
induces the secretion of IFN-b, IL-6, IL-8, and RANTES. Elevated
levels of pro-inﬂammatory cytokines and chemokines, such as
TNF-a, IL-6, IL-8, MCP-1, IL-10, IL-12, IFN- g and MIF, are detected
during severe dengue (Hober et al., 1993; Bethell et al., 1998;
Chaturvedi et al., 1999; Huang et al., 2000; Azeredo et al., 2001;
Assunc- ~ao-Miranda et al., 2010). The importance of the inﬂamma-
tory cytokines in the disease is further evidenced by the fact that
plasma leakage occurs after the peak of viremia and deferves-
cence, when the highest levels of cytokine and chemokine
production are detected (Rothman, 2011). During infection,
endothelial cells are in constant contact with the virus and with
endogenous molecules and cytokines released due to tissue
damage and activation of other cell types. These interactions
may induce the production of pro-inﬂammatory cytokines, che-
mokines, as well as structural changes in the cells, allowing
leukocyte and platelets recruitment, adhesion and activation
(Talavera et al., 2004; Kelley et al., 2012). These responses may
participate in the control of the infection, but an exacerbated
activation of the endothelium can amplify the inﬂammatory
response and contribute to coagulopathy and increased vascular
permeability.
Direct infection of endothelial cells from different tissues by
DENV has been largely described in vitro (Bonner and O’Sullivan,
1998; Yen et al., 2008; Are´valo et al., 2009; Zamudio-Meza et al.,
2009; Martı´nez-Gutierrez et al., 2011; Dalrymple and Mackow,
2011) and in vivo (Jessie et al., 2004; Chen et al., 2007; Balsitis
et al., 2009; Zellweger et al., 2010) including the infection of brain
tissue (Ramos et al., 1998). The infection of endothelial cells has
been associated to cellular activation (Avirutnan et al., 1998;
Huang et al., 2000; Bosch et al., 2002; Azizan et al., 2006), but the
mechanisms underlying this activation are not completely
known. Also, it was reported that endothelial cells from different
tissues may differently behave when infected by DENV (Peyreﬁtte
et al., 2006).
Our data revealed that the infection of HBMECs with DENV
resulted in an upregulation of the expression of RIG-I, a PRR
related to viral RNA sensing in the cytoplasm, and to the
stimulation of signal transduction pathways correlated to the
production of IFN-b and inﬂammatory cytokines. Silencing of RIG-I
gene expression by small interference RNA in HBMECs strongly
inhibited DENV-mediated expression and secretion of IFN-b, IL-6
and RANTES, but not IL-8 . Activation of RIG-I-mediated inﬂam-
matory response has been demonstrated in a few virus infection
models, including infection of astrocytes with vesicular stomatitis
virus (VSV), neuron infection with Japanese encephalitis virus
Fig. 5. RIG-I silencing using small interference RNA (siRNA). HBMECs were
transfected with RIG-I speciﬁc siRNA using lipofectamine and, 48 h after transfec-
tion, cells were infected with DENV at a M.O.I. of 1. (A) After 24 and 48 h of
infection the expression of RIG-I mRNA was evaluated by quantitative real time
PCR using speciﬁc primers for RIG-I; mock treated and DENV-infected cells are
represented by white and black bars, respectively. (B) The expression of RIG-I
protein was assessed by western blotting analysis of the whole-cell lysates
submitted to SDS-PAGE using anti-RIG-I antibody and anti-a-tubulin antibody
as loading control. Bar graphic indicate the ratio of RIG-I protein over loading
control. Data are represented as mean7standard error of at least three indepen-
dent experiments. *po0.05, in relation to mock-treated cells; and **po0.05, in
relation to DENV-infected cells.
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Nazmi et al., 2011; Saito et al., 2007; Sumpter et al., 2005).
Regarding DENV, it was recently demonstrated that infection of a
mast cell-like line led to an upregulation of RIG-I expression,
associated to the secretion of chemokines and IFN, and to a
cellular antiviral response (St John et al., 2011). In addition, the
PRR-mediated activation of mast cells upon DENV infection
seemed to participate in the recruitment of NK and NKT cells,
contributing to the in vivo control of virus replication.
Innate immune response against RNA viruses, actually, result
from an intricate interaction between different PRRs. RIG-I and
MDA-5 RNA helicases, in particular, are closely related proteins
and both signal through the same adaptor protein (Cardif/MAVS/
IPS-1) to activate the expression of IFN-stimulated genes (ISG)
(Kawai et al., 2005; Johnson and Gale, 2006). However, several
reports demonstrated that these receptors may not be alwaysfunctionally redundant even if both are upregulated upon a given
infection (Kato et al., 2006; Gitlin et al., 2006; Le Gofﬁc et al.,
2007; Liao et al., 2008; Saito et al., 2007; Sumpter et al., 2005;
Triantaﬁlou et al., 2011; Wang et al., 2009).
It was previously demonstrated that Cardif/MAVS/IPS-1 sig-
naling is important for the initial innate response during dengue
infection in a mouse experimental model, suggesting that RIG-I,
MDA-5 or both receptors regulates anti-dengue response in vivo
(Perry et al., 2009). In vitro experiments, however, suggest that
activation of antiviral and inﬂammatory response by DENV seems
to be complex and may involve different PRRs depending on the
event that is being investigated, the cell type analyzed, or the
infection model. Huh7 hepatic cell line expressed higher levels of
IFN-b by a mechanism dependent on a crosstalk between differ-
ent PRRs, including RLRs and TLRs (Nasirudeen et al., 2011).
Similarly, DENV-mediated IRF response in mouse embryonic
ﬁbroblasts (MEF) and lung epithelial carcinoma cells (A549)
showed to be dependent on RIG-I and MDA-5 (Loo et al., 2008;
Qin et al., 2011). On the other hand, increased expression of IFNb,
TNFa, and defensins induced by DENV-2 in human primary
ﬁbroblasts was dependent on RIG-I and TLR-3, but not MDA-5
signaling (Bustos-Arriaga et al., 2011). The human hepatoma cell
line HepG2 also presented higher levels of RIG-I, MDA-5, TLR3,
and TLR8, and increased production of IFN-b, IL-6, IL-8 and
RANTES when infected by DENV, but the relation between PRRs
and cytokine production was not addressed (Conceic- ~ao et al.,
2010a). We observed that, besides RIG-I, MDA-5 and Lgp-2 were
highly expressed in DENV-infected HBMECs. Our data also sug-
gested that the infection resulted in a crosstalk between those
RNA helicases, given that RIG-I ablation led to an inhibition of
MDA-5 and Lgp-2 mRNA expression. However, the detailed role of
all the viral sensors and the regulation between them upon DENV
infection of HBMECs require further investigation.
Interestingly, we observed that in a HBMEC culture incubated
with DENV, both infected and non-infected (bystanders) cells
presented an increased RIG-I expression. This suggests that some
molecules expressed or released by the infected cells are affecting
the activation of bystander cells. DENV infection is associated to
apoptosis of endothelial cells (Va´squez Ochoa et al., 2009; Liao
et al., 2010), and, therefore, the RNA molecules derived from
apoptotic bodies or cellular debris could be inﬂuencing RIG-I
expression in the bystander cells. Even though the molecular
mechanisms related to this enhancement need further investiga-
tion, we believe that it may contribute to the pronounced
production of IFN-b and inﬂammatory cytokines observed.
The direct role of RIG-I activation in endothelial cells during
DENV infection was not addressed before, but upregulation and
activation of this receptor after endothelial cell contact with a
synthetic dsRNA, poly IC, was previously demonstrated (Imaizumi
et al., 2005). Human coronary endothelial cells stimulated with a
RIG-I ligand upregulated RIG-I expression and secreted high levels
of inﬂammatory cytokines. Also, mice treatment with the same
ligand presented alterations in vascular oxidative stress and
endothelium-dependent vasodilation, suggesting that RIG-I acti-
vation may contribute to endothelial dysfunction (Asdonk et al.,
2012). Stimulation of glomerular endothelial cells with poly IC
induced the production of IL-6, CCL2, CCL5, CXCL10, IFN-a and
IFN-b in a RIG-I-dependent way. Addition of complexed RNA to
the cultures also induced the expression of ICAM-1 and increased
the permeability of the monolayer, but the role of RIG-I in these
events was not addressed (Ha¨gele et al., 2009).
In our system, DENV-induced RIG-I activation also stimulated
an upregulation of ICAM-1 expression on the surface of HBMECs.
Expression of adhesion molecules, such as VCAM-1, ICAM-1 and
E-selectin, was previously demonstrated to be upregulated when
DENV-infected endothelial cells were cultured with inﬂammatory
Fig. 6. Induction of cytokines and type I interferon observed during DENV infection of HBMEC is mediated by RIG-I activation. HBMECs were transfected with RIG-I speciﬁc
siRNA using lipofectamine and, 48 h after transfection, cells were infected with DENV at a M.O.I. of 1. After 24 and 48 h of infection cytokine production was evaluated by
(A) the expression of mRNA for IL-6, IL-8, RANTES, and IFN-b by quantitative real time PCR using speciﬁc primers; and (B) the concentration of IL-6, IL-8, and RANTES in the
culture supernatants by ELISA. Mock-treated and DENV-infected cells are represented by white and black bars, respectively. Data are represented as mean7standard error
of at least three independent experiments. *po0.05 in relation to mock-treated cells; and **po0.05 in relation to DENV-infected cells.
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the activation of this process by direct infection of endothelial cell
has not been distinctly addressed before. ICAM-1 expression is
essential for adhesion, paracellular and transcellular migration of
neutrophils (Yang et al., 2005), and the interaction of these cells
with the endothelium can increase vascular permeability (DiStasi
and Ley, 2009). Therefore, an increase in ICAM-1 expression could
contribute to endothelial alteration mediated by polymorpho-
nuclear cells. Indeed, neutrophil recruitment was clearly demon-
strated in an in vivo experimental model of dengue and seems to
be a marker of severe disease (Guabiraba et al., 2010). Also, high
levels of soluble ICAM is observed in severe dengue patients,being an indicative of endothelium injury (Cardier et al., 2006).
Stimulation of ICAM-1 expression due to RIG-I activation was
previously demonstrated in endothelial cells cultured with poly IC
(Ha¨gele et al., 2009), but the role of this pathway in an actual
virus infection had not been addressed until now. In our model,
ICAM-1 expression was accompanied by an increase in cytokine
secretion, but whether it was a direct effect of RIG-I stimulation
or resulted from autocrine effects mediated by the cytokines
should be further investigated. Infection of endothelial cells with
respiratory syncytial virus (RSV) also induces pro-inﬂammatory
cytokine secretion and ICAM-1 upregulation. In this model,
neutralization of IL-1a, IL-1b, IL-6, or TNF-a did not abolish
T.M. da Conceic- ~ao et al. / Virology 435 (2013) 281–292288ICAM-1 expression, excluding an autocrine mechanism (Arnold
and Ko¨nig, 2005).
Inhibition of RIG-I expression in HBMECs infected by DENV did
not result in an increased virus replication, in spite of the down-
regulation of IFN-b production. Although IFN response is important
for DENV replication control in vivo (Shresta et al., 2004) and in vitro
(Diamond et al., 2000; Dai et al., 2011), it has been reported that
DENV evolved strategies to counteract IFN responses. IFN-mediated
antiviral response is initiated by the engagement of IFN receptors
and activation of the JAK/STAT signaling pathway. Phosphorylation
and activation of STAT transcription factors promote the stimulation
of interferon-stimulated responsive elements (ISRE), inducing the
expression of antiviral proteins. It was reported that DENV non-
structural proteins are able to block phosphorylation and activation
of major components of JAK/STAT pathway and to inhibit ISREFig. 7. DENV infection induces a RIG-I-dependent upregulation of ICAM-1.
HBMECs were transfected with RIG-I speciﬁc siRNA using lipofectamine and,
48 h after transfection, cells were infected with DENV at a M.O.I. of 1. After 48 h
post-infection, the whole-cell lysates were submitted to SDS-PAGE and analyzed
by western blotting using anti-ICAM-1 antibody and anti-b-actin antibody as a
loading control. Bar graphic indicate the ratio of ICAM-1 protein over loading
control; mock-treated and DENV-infected cells are represented by white and black
bars, respectively. Data are represented as mean7standard error of at least three
independent experiments. *po0.05, in relation to mock-treated cells; and
**po0.05, in relation to DENV-infected cells.
Fig. 8. RIG-I activation does not interfere in viral replication. HBMECs were transfecte
were infected with DENV at a M.O.I. of 1. Productive infection was assessed at 48 h p.i. b
primers and probe; and (B) determination of infectious virus particles in the supernatan
at least three independent experiments.promoters, evading IFN-stimulated antiviral responses (Mun˜oz-
Jorda´n et al., 2005; Mun˜oz-Jorda´n, 2010). Therefore, induction of
IFN-b alone seems not to be determinant to inhibit virus replication
in all cell types.
Taken together, our data demonstrated that HBMECs are
permissive to DENV infection and cell–virus interaction induces
an upregulation of RIG-I expression, which is associated to an
increased production of type I IFN, inﬂammatory cytokines and
adhesion molecules. In addition, RIG-I activation by itself was not
associated to a cellular antiviral response, indicating that the
relevance of RIG-I for dengue pathogenesis may be related to
cytokine release and an increased expression of adhesion mole-
cules, probably contributing to leukocyte recruitment and ampli-
ﬁcation of the inﬂammatory response. The investigation regarding
whether the endothelial-mediated inﬂammatory response depen-
dent on RIG-I is associated to virus replication control or exacer-
bated inﬂammation and endothelium injury may enlighten new
aspects of dengue disease.Material and methods
Cells and virus
Human brain microvascular endothelial cells (HBMEC) have
been previously described (Nikolskaia et al., 2006) and were
kindly given by Dr. Dennis J. Grab (The Johns Hopkins University,
MD, USA). The cells were cultured in Medium 199 (Life Technol-
ogies), pH 7.4, supplemented with 10% fetal bovine serum (FBS)
(Life Technologies), in a CO2 humid incubation chamber, at 37 1C.
C6/36 mosquito cell line were cultured, at 28 1C, in Leibovitz
(L-15) medium (Life Technologies) supplemented with 10% of
tryptose phosphate broth (Sigma), 0.75% sodium bicarbonate
(Sigma), 0.2% of L-glutamine (Sigma), and 10% FBS.
BHK cell line was cultured in Minimum Essential Medium
Alpha medium (Alpha MEM; Life Technologies) supplemented
with 10% inactivated fetal bovine serum, in a humidiﬁed incu-
bator at 37 1C in 5% CO2.
DENV serotype 2, Asiatic strain 16681, was propagated in the
C6/36 cell line. The cells were grown until semi-conﬂuence in L-
15 medium, supplemented with 10% FBS, and then incubated
with DENV with a multiplicity of infection (MOI) of 0.02 pfu/cell.
After 1 h incubation, the cells were washed and cultivated in fresh
medium supplemented with 2% FBS for 9 days. After this period,d with RIG-I speciﬁc siRNA using lipofectamine and, 48 h after transfection, cells
y (A) quantiﬁcation of viral RNA by quantitative real time PCR using DENV speciﬁc
t of infected cells by plaque assay. Data are represented as mean7standard error of
Fig. 9. RIG-I silencing inhibit MDA-5 and Lgp-2 expression induced by DENV infection. HBMECs were transfected with RIG-I speciﬁc siRNA using lipofectamine and, 48 h
after transfection, cells were infected with DENV at a M.O.I. of 1. After 48 h of infection the expression of mRNA for MDA-5 and Lgp-2 were evaluated by quantitative real
time PCR using speciﬁc primers. Data are represented as mean7standard error of at least three independent experiments. *po0.05 in relation to DENV-infected cells.
Table 1
Primer sequences for real-time PCR assay.
Primer Orientation Sequence Product
size (bp)
DV Forward Sense 50-ATTAGAGAGCAGATCTCTG-30 80
DV Probe 50-TCAATATGCTGAAACGCG-30
DV Reverse Antisense 50-TGACACGCGGTTTC-30
RIG-I Sense 50-TGTTCTCAGATCCCTTGGATG-30 234
Antisense 50-CACTGCTCACCAGATTGCAT-30
IL-6 Sense 50-TGTGAAAGCAGCAAAGAGGCACTG-30 194
Antisense 50-ACAGCTCTGGCTTGTTCCTCACTA-30
IL-8 Sense 50-CAGCCAAAACTCCACAGTCA-30 155
Antisense 50-TTGGAGAGCACATAAAAACATCT-30
RANTES Sense 50-GAGGCTTCCCCTCACTATCC-30 155
Antisense 50-CTCAAGTGATCCACCCACCT-30
IFN-b Sense 50-TAGCACTGGCTGGAATGAGA-30 186
Antisense 50-TCCTTGGCCTTCAGGTAATG-30
GPDH Sense 50-GTGGACCTGACCTGCCGTCT-30 153
Antisense 50-GGAGGAGTGGGTGTCGCTGT-30
T.M. da Conceic- ~ao et al. / Virology 435 (2013) 281–292 289culture medium was collected and centrifuged to remove cellular
debris and the supernatant containing the viruses were stored at
80 1C until use. The stock virus titer was determined by plaque
forming assay in BHK cells, as described previously (Conceic- ~ao
et al., 2010a). Supernatants of noninfected C6/36 cells cultured in
the same conditions were used as mock controls. Inactivated virus
was obtained after UV exposition for 2 h and the inactivation was
conﬁrmed by plaque assay and RT-PCR in BHK cells.
HBMEC infection
HBMECs were incubated with DENV2, with a MOI of 1 (except
when indicated), for 1 h at 37 1C in 5% CO2 atmosphere. As a
control, the cells were incubated with supernatant of noninfected
C6/36 cells (mock-infected) or UV-inactivated DENV (iDENV).
Cells were, then, washed with phosphate buffer saline (PBS) and
cultured with complete medium for different time points,
depending on the performed analysis, as indicated later.
RNA isolation and cDNA synthesis
Cells were harvested at the indicated periods post-infection
and their RNA was isolated using TRIZOL reagent (Life Technol-
ogies), according to the manufacturer’s instructions. Treatment
with DNAse I (Fermentas) was then performed to prevent geno-
mic DNA contamination. First strand cDNA was synthesized using
2 mg of the RNA extracted from mock-treated or DENV-infected
cells using High-Capacity cDNA Archive Kit (Life Technologies),
according to the manufacturer’s instructions.
DENV RNA quantiﬁcation by TaqMan real-time PCR
cDNAs prepared as described above (1 ml) were subjected to
quantitative real-time PCR for detection of viral RNA using a
StepOnePlus Real-time PCR system (Life Technologies) and Taq-
man Master Mix Reagents (Life Technologies), using primers and
probe speciﬁc for a 5’UTR sequence, as described elsewhere
(Conceic- ~ao et al., 2010b). The data are presented as the mean of
at least three independent experiments with respective standard
errors.
Cell viability assay
Determination of HBMEC viability during infection was carried
out using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) (USB Corporation). For the assay, cells seeded in a12-well cell culture plate were mock-infected or infected with
DENV in different multiplicities of infection (M.O.I.). At 24 and 48
post-infection, the medium was removed, the cells were washed
and the MTT solution (5 mg/ml) was added to each well. After 2 h
of incubation at 37 1C, the supernatant was aspirated and 0.5 ml
of 0.04 M HCl in isopropanol solution used to dissolve water-
insoluble purple formazan crystals. The absorbance was mea-
sured using a spectrophotometer and data represents the mean of
three independent experiments with standard errors.
SYBR green real-time PCR
To analyze the expression of PRRs and cytokines, cDNAs
prepared as described above were 5-fold diluted and 1 ml of each
sample was submitted to real-time PCR using Power SYBR Green
PCR master mix (Life Technologies). The reaction was carried out
for the selected genes using gene speciﬁc primers (Table 1) and a
StepOnePlus Real-time PCR system (Life Technologies). The sam-
ples were subjected to a ﬁrst step at 95 1C for 10 min followed by
40 ampliﬁcation cycles consisting of DNA denaturation for 30 s at
95 1C, and annealing of primers for 30 s at 60 1C. The threshold
cycles (Ct) for each gene of interest and for the house keeping
T.M. da Conceic- ~ao et al. / Virology 435 (2013) 281–292290gene (glycerol 3-phosphate dehydrogenase, GPDH) were deter-
mined. The relative expression for each gene was calculated as
described elsewhere (Conceic- ~ao et al., 2010a). Two-tailed t-test
was used to ascertain data statistical signiﬁcance.
Flow cytometry analyses
Cells were harvested at 24 and 48 h after infection, ﬁxed with
4% formaldehyde for 10 min, permeabilized with 0.1% saponin,
and blocked with PBS containing 2% fetal bovine serum and 1%
bovine serum albumin for 20 min. The cells were stained with
mouse anti-DENV antibody (Millipore) followed by incubation
with anti-mouse IgG antibody conjugated Alexa ﬂuor-488 (Life
Technologies) and/or with rabbit anti-RIG-I antibody (Santa Cruz
Biotechnology) followed by incubation with anti-rabbit IgG anti-
body conjugated to PE Cy5.5 (Life Technologies). The samples
were analyzed in a FACScalibur cytometer, using CellQuest soft-
ware (Becton Dickson Immunocytometry System).
Immunoblotting analyses
Cellular extracts were prepared in RIPA buffer (50 mM Tris,
150 mM NaCl, 1% NP40, 1 mM EDTA and 0.25% sodium deox-
ycholate) and subjected to SDS-PAGE 10% followed by electro-
transfer to a nitrocellulose membrane (Thermo Fisher Scientiﬁc
Inc.). The nitrocellulose membranes were blocked in TBS buffer
0.01% Tween 20 containing 5% nonfat dry milk for 1 h. The
membranes were then incubated with primary antibodies, anti-
a-tubulin, anti-RIG-I, anti-ICAM-1, and anti-b-actin (Santa Cruz
Biotechnology), overnight at 4 1C, followed by incubations with
horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG
antibodies (Santa Cruz Biotechnology). Super Signals West Pico
Chemiluminescent Substrate (Thermo Scientiﬁc) was used for
protein detection according to the manufacturer’s instructions.
The ratio of interest protein/constitutive protein was determined
using ScionImage software.
ELISA
Cytokine concentrations in the cell culture medium were
quantiﬁed at 24 and 48 h post-infection by ELISA. IL-6 and IL-8
concentrations were determined using ELISA Ready-SET-Go!
(eBiosciences) and RANTES concentration was determined using
the ELISA Development Kit (PeproTech), according to manufac-
turer’s instructions.
RIG-I gene silencing
Cells were transiently transfected with RIG-I small interfering
RNA (siRNA) (Santa Cruz Biotechnology). Brieﬂy, cells were plated
at a density of 2105 cells/well in a six-well plate. After 24 h,
transfection was performed using Lipofectamine (Invitrogen) and
30 pmol of siRNA according to the manufacturer’s instructions.
The silencing of RIG-I gene was analyzed by real-time PCR or
western blotting at the indicated time points. As a control,
HBMECs were transfected with a scrambled RNAi (Santa Cruz
Biotechnology) at the same concentration.
Statistical analysis
The mean and SD were calculated for each experimental
group. Differences between groups were analyzed by the Student
t test for unpaired samples using the PRISM statistical analysis
software (GraphPadSoftware, Inc., San Diego, CA). Results with
po0.05 were considered signiﬁcant.Acknowledgments
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